Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇨🇦CA · Medicine#1365K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 9K🎙 Daily cadence·129 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇨🇦100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Recent guests
No guests detected in recent episodes.
Recent episodes
**Ozempic Beyond Weight Loss: Heart Protection, Supply Stability, and Lifestyle Integration**
May 2, 2026
6m 06s
# Ozempic Generic Approval and Medicare Coverage Expansion Transform Access in 2026
Apr 25, 2026
6m 41s
Ozempic Breakthroughs: Genetic Resistance, Safety Concerns, and Natural Alternatives Emerge
Apr 18, 2026
6m 09s
# Ozempic Reshapes Food, Brain, and Medicine: Latest Developments Explained
Apr 11, 2026
7m 05s
# GLP-1 Medications Transform Weight Loss Market as Safety Concerns Emerge
Apr 4, 2026
5m 05s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/2/26 | **Ozempic Beyond Weight Loss: Heart Protection, Supply Stability, and Lifestyle Integration**✨ | Ozempicweight loss+5 | — | OzempicWegovy+9 | — | Ozempicweight loss+8 | — | 6m 06s | |
| 4/25/26 | # Ozempic Generic Approval and Medicare Coverage Expansion Transform Access in 2026✨ | Ozempic newsgeneric medication+5 | — | Ozempicsemaglutide+4 | United States | Ozempicsemaglutide+7 | — | 6m 41s | |
| 4/18/26 | Ozempic Breakthroughs: Genetic Resistance, Safety Concerns, and Natural Alternatives Emerge✨ | Ozempicgenetic resistance+5 | — | OzempicWegovy+5 | NAIONReddit | OzempicGLP-1+7 | — | 6m 09s | |
| 4/11/26 | # Ozempic Reshapes Food, Brain, and Medicine: Latest Developments Explained✨ | Ozempicweight loss+4 | — | Ozempicsemaglutide+3 | — | Ozempicsemaglutide+6 | — | 7m 05s | |
| 4/4/26 | # GLP-1 Medications Transform Weight Loss Market as Safety Concerns Emerge✨ | GLP-1 medicationsweight loss+4 | — | FoundayoOzempic+5 | — | OzempicFoundayo+8 | — | 5m 05s | |
| 3/28/26 | Ozempic Beyond Weight Loss: Mental Health, Heart Protection, and Addiction Recovery✨ | mental healthcardiovascular protection+4 | — | Ozempicsemaglutide+4 | — | Ozempicsemaglutide+6 | — | 6m 04s | |
| 3/21/26 | Ozempic Breakthrough: Weight Stays Off After Stopping, But Heart Benefits Fade Fast✨ | weight lossheart health+4 | — | OzempicMounjaro+4 | United States | Ozempicweight regain+5 | — | 6m 07s | |
| 3/14/26 | FDA Warns Novo Nordisk Over Ozempic Safety Reporting Failures and Deaths✨ | Ozempic safety concernsFDA oversight+4 | — | OzempicWegovy+4 | — | OzempicFDA warning+7 | — | 6m 34s | |
| 3/7/26 | # Ozempic's Hidden Powers: Heart Health, Addiction, and Global Access Breakthroughs✨ | Ozempicheart health+4 | — | OzempicWegovy+3 | developing countries | OzempicWegovy+6 | — | 7m 18s | |
| 2/28/26 | Novo Nordisk Cuts Ozempic and Wegovy Prices by Up to Fifty Percent Starting 2027✨ | medication pricingweight loss medications+4 | — | OzempicWegovy+3 | — | OzempicWegovy+7 | — | 5m 04s | |
| 1/17/26 | Ozempic Unveiled: Legal Battles, Medical Breakthroughs, and the Evolving Landscape of a Groundbreaking Medication✨ | Ozempicsemaglutide medications+5 | — | Ozempicsemaglutide+2 | CanadaUnited States | Ozempicsemaglutide+6 | — | 4m 34s |
Showing 11 of 11
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.